The aim of the PEPSI study is to use genotypic resistance testing to find out which factors influence the genetic material of hepatitis C viruses (HCV) and thus trigger treatment failure (resistance).
To offer you an optimal experience, we use technologies such as cookies. This site does not use cookies to store personal data, but only technically technically necessary cookies such as the session cookie. To the privacy policy